Global Facial Injectables Market
Facial Injectables Market size is assessed at USD 12.12 Billion in 2024 and is expected to cross USD 46 Billion by the end of 2037, registering more than 10.86% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of facial injectables is evaluated at USD 13.35 Billion.
The growth of the facial injectables market is set to be dominated by growing concerns among the geriatric population related to face wrinkles, fine lines, and volume loss. For instance, as per the predictions of the World Health Organization, 1 in 6 people across the globe by 2030, is predicted to be aged 60 years or over. Therefore, facial injectables are ideal for the aged population who want fresh skin.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.86% |
|
Base Year Market Size (2024) |
USD 12.12 Billion |
|
Forecast Year Market Size (2037) |
USD 46 Billion |
|
Regional Scope |
|
Product (Collagen, Hyaluronic Acid [HA], Botulinum Toxin Type A, Calcium Hydroxylapatite [CaHA], Polymer Fillers)
By 2037, botulinum toxic type A segment in the facial injectables market is estimated to reach USD 21.05 billion up from a revenue of USD 5.45 billion in the year 2024. Botulinum toxin type A, additionally referred to as Botox, is a key component in the cosmetic injectables industry because it targets the underlying cause of wrinkles that result from muscle spasms. Unlike fillers, which enhance volume, Botox works by briefly relaxing certain facial muscles. This eliminates recurrent muscle contractions, which allow wrinkles to develop and deepen, especially on the top face.
Botox injections are very effective in treating frown lines, crow's feet, and forehead wrinkles. Therefore, with the growing prevalence of wrinkles, the segment is set to observe exponential growth. Furthermore, this prevalence could be influenced not only by old age but also by growing consumption of smoking, pollution, and more. For instance, according to the International Energy Agency, CO2 emissions in 2021 across the globe rose by over 2 billion which is the highest in history. Therefore, with the growing prevalence of people with wrinkles, the segment is estimated to expand.
Application (Wrinkle Reduction, Facelift, Acne Scar Treatment, Lipoatrophy Treatment, Lip Enhancement, Others)
In facial injectables market, facelift segment is expected to cross USD 13.22 Billion by 2037. This growth is set to be highest in contrast to the year 2024 when revenue is predicted to rise to USD 3.43 billion. The main benefits of facial injectables for facelift utilization over other surgical solutions involve minimally invasive techniques with no downtime or incisions, natural-looking results, a gradual approach that motivates patients to choose conservative treatment, and an affordable strategy with shorter recovery time and no anesthesia required. There are several limits, including transient results and a less favorable method for individuals with substantial sagging and deep wrinkles.
Overall, facial injectables are a successful technique for obtaining a non-surgical facelift result. They provide an effective way to achieve a more young and refreshed appearance. Furthermore, the rising disposable income is also encouraging segment growth. According to Euromonitor International, the worldwide disposable incomes and expenditure per household in 2022 are both anticipated to increase by 2.6%.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
Application |
|
|
End-User |
|
North American Market Statistics
North America facial injectables market size is predicted to cross USD 14.7 Billion by 2037, up from a revenue of USD 3.75 billion in the year 2024. This growth of the market in this region is set to be dominated by rising spending on cosmetics. In 2022, it was predicted that over USD 721 will be spent by people in America on appearance. Hence, the demand for facial injectables is also set to rise over the projected timeframe.
The market in the US for facial injectables is predicted to gather the highest market revenue over the forecast period. This could be owing to the rising number of young population in this region.
Additionally, the Canadian market is also set to experience growth in this region on account of the growing consumption of alcohol which is causing premature aging.
APAC Excluding Japan Market Analysis
Asia Pacific facial injectables market, excluding Japan is likely to showcase over 11.33% growth rate through 2037. The major factor driving the market expansion in this region is the growing middle-class population. As per the predictions of the World Economic Forum, in 2020, over 2 billion population of Asians were middle class and this number is poised to grow to 3.5 billion by 2030. Hence, the spending of the middle-class population is also high on appearance.
In this region, the market in China for facial injectables is poised to rise at a revenue of USD 3.63 billion over the years to come owing to the growing urban population.
Moreover, with the surge in investment in surgical procedures the market in India for facial injectables is projected to have notable growth.
Furthermore, the market in South Korea is also expected to expand at a significant pace. This growth is set to be encouraged by a larger number of options available.
The facial injectables market consists of a number of major players who are launching various products in the market which is additionally influencing the market growth. Some of them include:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?